Remove 2019 Remove Complication Remove Family Remove Illness
article thumbnail

Overtreatment of prostate cancer in the active surveillance era

Common Sense Family Doctor

Concerns about overdiagnosis of clinically insignificant prostate cancer through prostate specific antigen (PSA) screening motivated the 2018 American Academy of Family Physicians’ (AAFP) recommendation against routine screening for prostate cancer. in 2019, with 78% receiving radiation therapy and 22% undergoing surgery.

article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

Two of our guests today, Stacy Fischer and Brian Anderson, are involved in large multicenter trials of psychedelics for patients with advanced cancer (Fischer) or life-limiting illness (Anderson). In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Eric: Yeah.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Private Equity Gobbling Up Hospices plus Hospice and Dementia: Melissa Aldridge, Krista Harrison, & Lauren Hunt

GeriPal

And yet, disenrollment from hospice, either due to patient/family revoking the benefit or stabilization of illness (extended prognosis) is remarkably high for people with dementia among some hospices. In fact, as Lauren Hunt found , the average likelihood that a person will be disenrolled from one hospice vs. another is two.

Families 106
article thumbnail

‘Not Accountable to Anyone’: As Insurers Issue Denials, Some Patients Run Out of Options

Physician's Weekly

But that’s when his family began fighting another adversary: their health insurer, which decided the treatment was “not medically necessary,” according to insurance paperwork. When the Tennant family was told histotripsy would cost $50,000 and insurance wouldn’t cover it, they appealed the denial four times.